Across TCGA pan-cancer cohorts, ARMH1 Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated ARMH1 data layer compared with 22 for mass-spec protein.

The strongest signal is observed in small cell lung cancer (SCLC), where higher ARMH1 Mutation is associated with worse disease-free survival. In most high-consensus cancer types, elevated ARMH1 expression acts as an unfavorable survival marker.

SCLC and ESCA are the cancer types where ARMH1 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
SCLC	DFS	Median	II,III,IV	0.082	0.564	.002	36	view →
ESCA	OS	Median	II,III,IV	0.130	0.703	<.001	24	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: ARMH1 tumor-vs-normal RNA expression · all ARMH1 data types